Mus vs Uzbekistan: The number of people with susceptibility test result for rifampicin
Mus
100
in 2021
Uzbekistan
100
in 2021
Mus rank
1st
Uzbekistan rank
2nd
The number of people with susceptibility test result for rifampicin over time
- Mus
- Uzbekistan
How they compare
Mus currently reports 100 against 100 in Uzbekistan, a difference of 0.
The two have swapped places 1 time across 5 shared years of data; in 2017 it was Mus ahead.
Mus ranks 1st and Uzbekistan ranks 2nd of 2 regions.
Mus has averaged higher in every one of the 2 decades both report.
Head to head by decade
| Decade | Mus | Uzbekistan | Difference | Ahead |
|---|---|---|---|---|
| 2010s | 100 | 98.89 | 1.11 | Mus |
| 2020s | 100 | 100 | 0 | — |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher the number of people with susceptibility test result for rifampicin, Mus or Uzbekistan?
- Mus, at 100 against 100 in Uzbekistan as of 2021.
- What is the difference in the number of people with susceptibility test result for rifampicin between Mus and Uzbekistan?
- 0, with Mus ahead.
- How many years of comparable data are there for Mus and Uzbekistan?
- 5 years are reported by both, from 2017 to 2021.
- How do Mus and Uzbekistan rank globally for the number of people with susceptibility test result for rifampicin?
- Mus ranks 1st and Uzbekistan ranks 2nd of 2 regions.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients expressed as percentage.. Statizoid refreshes it automatically from the source and publishes the full history for both places.